directSTIM
Commercial- Indications
- Parkinson's disease, Essential tremor
Company intelligence / Profile preview
Aleva Neurotherapeutics
Lausanne, Vaud, Switzerlandaleva-neuro.com ↗
- Ownership
- Private
- Employees
- ~53
- Development stage
- Commercial
01
Overview
Aleva Neurotherapeutics has commercialized its directSTIM™ Directional Deep Brain Stimulation system for the treatment of Parkinson’s disease and essential tremor. The technology offers more precise stimulation with fewer side effects compared to traditional DBS systems. Clinical results have demonstrated improved outcomes due to directional stimulation capabilities. The company holds over a dozen patent families and has established partnerships with leading European neurological clinics.
- Therapeutic areas
- Neurology
- Modalities
- DeviceNeuromodulation deviceDeep Brain Stimulation system (DBS)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Leading neurological clinics in Europe
Beyond the preview
Go deeper on Aleva Neurotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aleva Neurotherapeutics.